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adolescents with antisocial behaviour: study
protocol of a randomized controlled trial
Danielle EMC Jansen1,2*, Karin M Vermeulen3, Annemieke H Schuurman-Luinge1, Erik J Knorth4,
Erik Buskens3 and Sijmen A Reijneveld1Abstract
Background: Multisystemic Therapy (MST) is an intensive, short, family- and community-based treatment for serious
antisocial behaviour and delinquency in youth. It is an emerging intervention for serious juvenile delinquents.
However, conclusive evidence on the balance between costs and effects is limited and in fact non-existent for the
Netherlands. The aim of this protocol is to describe the design of a study to evaluate the cost-effectiveness of MST
as compared to Care-As-Usual (CAU).
Methods: The cost-effectiveness of MST will be assessed through a Randomised Controlled Trial. Primary outcomes
aggressive and delinquent behaviour will be assessed with the parent-reported CBCL and adolescent-reported YSR.
Health care utilisation, production loss, and quality of life are recorded using the self-report 'Trimbos and iMTA
questionnaire on Costs associated with Psychiatric illness' (TiC-P), and with the MOS Short-Form General Health
Survey (SF-20) and EuroQol -5D (EQ-5D), respectively. The study aims to enrol 100 clients in both conditions (MST
and CAU). Data will be obtained before treatment (T1), immediately after treatment (T2; 5 months after T1) and at
follow up (T3; 6 months after the end of the treatment) from a variety of sources, i.e. clients, parents/primary carers,
professionals and police records.
Discussion: Studying the cost-effectiveness of this treatment for youth antisocial behaviour is important in order to
provide information to policy makers on whether the provision of this intervention represents good value for
money. Introducing a cost-effective evidence based programme may result in valuable health gains for moderate
costs.
Trial registration: NTR1390Background
The direct costs associated with antisocial and delin-
quent behaviour of adolescents are high. Estimated ex-
penses of incarceration amounted to 114.000 - 250.000
euro per youth per year [1,2]. The degree of recidivism
among juveniles who were incarcerated has been esti-
mated to be at least 75% in the first three years after re-
lease [3]. Besides direct costs of locking up offenders,* Correspondence: d.e.m.c.jansen@umcg.nl
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reproduction in any medium, provided the orincarceration also has wider costs and consequences. In-
direct costs include amongst other things extra support
for the adolescent to reintegrate into the education sys-
tem or the labour market and lost wages of parents due
to the high time demands of an incarcerated child [1].
As a result of the unfavourable outcomes of incarce-
ration, there is a strong need for evidence-based treat-
ments that can provide an alternative to incarceration
for youth with serious emotional and behavioural prob-
lems. Multisystemic Therapy (MST) has been proposed
as a promising, cost-effective intervention for this group
of young people. Several studies show significant reduc-
tions in number of serious crimes and days incarcerated
[4-6]. However, research conducted in Canada and
Sweden did not show significant differences in treatmentLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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review by Littell et al. [9] confirmed that the evidence
regarding the superiority of MST compared to CAU is
still inconclusive.
The introduction of an intensive family- and community-
based treatment such as MST will always be associated
with additional costs. Cost-effectiveness studies in child
and youth care are required to provide decision makers
with information on whether this intervention represents
good value for money. Therefore, studies are needed that
assess how well MST works – its influence on behaviour
and the use of health and welfare services – and how much
it costs. Cost-effectiveness analysis (CEA) is an approach
that combines these requirements.
Cost-effectiveness has hardly been studied in child and
youth care. MST is an example of a youth care interven-
tion. Available studies on cost-effectiveness of MST for ad-
olescents with antisocial behaviour revealed generally
positive results, but direct translation of previous findings
is not possible due to several factors. For example, the
study of Klietz et al. (2010) did not include the full
spectrum of youth care utilization in their cost-
effectiveness analysis [10]. In addition, the study of Olsson
(2009) focused only on the direct costs associated with
serious behavioural problems and overlooked indirect
costs such as productivity loss [11]. All these methodo-
logical differences across studies lead to an incomplete
overview of costs of MST [11]. To illustrate: in the study
of Olsson (2009), MST was found to cost more than
double that estimated in the studies of Aos et al. (2004)
and Schoenwald et al. (1996) [11,12].
The aim of the present study is to assess the balance
between direct and indirect costs and effects of MST in
the Netherlands as compared to Care-As-Usual for ado-
lescents with serious behavioural problems.
Methods
Trial design
The design of this cost-effectiveness study will be de-
scribed following the CONSORT statement [13]. The
study is a supplement to an MST-effectiveness study
[14], which concerns a randomized controlled trial
(RCT) with a follow-up measurement after 6 months.
Participants will be randomly assigned to one of the two
groups: MST or Care-As-Usual (CAU). Data will be col-
lected using a standardized self-report questionnaire in a
face-to-face situation before treatment (T1), immediately
after treatment (T2) and at follow up (T3; 6 months
after treatment) among adolescents, parents/primary
carers and therapists. Adolescents and their parents will
both receive €10 for filling out the questionnaire. The
Medical Ethics Committee of Utrecht University ap-
proved the study design, protocols, procedures and in-
formed consent. Participation is voluntary and allparticipants are asked to provide written informed con-
sent at T1.
Recruitment
Participants will be recruited via three MST institutions
spread over the Netherlands. The recruitment per
organization will differ because of differences in the setting
in which MST will be delivered. One MST organization is
located in the North of the Netherlands; the other two lo-
cations are in the West of the Netherlands.
In the North of the Netherlands, the study population
will consist of adolescents referred by family guardians
of the Youth Care Office to the youth care program
called “Do What Works”. This program consists of max-
imum six weeks secure residential care, followed by
MST (Intervention) or FFT (Functional Family Therapy;
Care-As-Usual). After the residential period, adolescents
will be randomized to MST or to Care-As-Usual. At the
same time, adolescents and their parents will be in-
formed about the MST-effectiveness study and they will
be asked for their informed consent. Upon mutual con-
sent of the adolescent and the parents, a first appoint-
ment will be made before the start of MST or Care-As
-Usual, in order to obtain written informed consent and
to administer the first questionnaire.
The recruitment in the Western part of the Netherlands
will be conducted via referring agencies such as Child Pro-
tection Council, juvenile judges, Bureaus Youth Care and
local referral institutions. The referrers will inform the po-
tential eligible juveniles and their families that a study will
be conducted to investigate the effectiveness of youth care.
If the families meet the inclusion criteria for MST
according to the MST supervisors of the participating in-
stitutions, research procedures will be explained to the ju-
veniles and their families, and their informed consent to
participate in the study will be obtained by researchers.
Participants
Participants eligible for this study are adolescents (and
their families) between 12 and 18 years old who show
serious, violent, and chronic antisocial behaviour. Exclu-
sion criteria are an IQ below 70, acute psychiatric prob-
lems that place adolescents and their family at risk for
out-of-home placement, and dominant sexual problems.
Adolescents may be court-ordered or referred by pri-
mary health care, social workers or self-referred.
Interventions
MST. Multisystemic Therapy (MST) is an intensive,
short-term, home- and community- based intervention
program for families of youth with severe psychosocial
and behavioural problems. It is based on the social eco-
logical theory of Bronfenbrenner [15] and on models of
the cause of delinquency [16]. MST is designed to
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alternative treatment for out-of-home placement of chil-
dren and youth. It uses the various systems in which the
adolescent is embedded: family, peer group, school and
neighbourhood. In consultation with the members of the
family, the therapist identifies a set of treatment goals
and assigns the tasks required to accomplish these goals.
MST lasts 4 to 6 months and takes the individual needs
of the client into account. Therapists are available 7 days
a week, 24 hours a day. Each team includes 3–5 thera-
pists who have a caseload of 3–5 clients each.
CAU. Care-As-Usual consists of treatments that are
already available for adolescents with severe psychosocial
and behavioural problems: juvenile justice services, child
welfare services, individual adolescent counselling and
home-based social services (for instance, parental coun-
selling). Also included and variably implemented across
regions are recently developed, evidence-based services
such as Functional Family Therapy (FFT) [17] and Multi-
Dimensional Family Therapy (MDFT) [18].
Randomization
Immediately after referral (Western part of the
Netherlands) or after the residential period (Northern
part of the Netherlands), participants will be random-
ized to MST or CAU with the use of a computerized
randomization program. This program will execute the
randomization separately for each site. The ratio of
randomization between MST and CAU will be 1:1.Outcome measures
In cost-effectiveness studies, costs are linked to treat-
ment or clinical outcomes. All outcomes will be assessed
at all three measurement moments.Primary outcomes
Primary outcomes of this study include: recidivism and
the frequency and seriousness of antisocial behaviour
and other types of problems (internalizing problems,
substance use). Recidivism will be assessed with data of
the Research and Policy Database for Judicial Documen-
tation. With this data we will assess the number of
arrests, type and severity of offence of adolescents re-
offending during the research period.
Prevalence and seriousness of antisocial behaviour will
be assessed via different informants and instruments.
First, parents and adolescents are asked to fill in the 33
items of the Delinquent Behaviour scale and the Aggres-
sive Behaviour scale of the Child Behaviour Checklist
(CBCL: 33 items) [19] and the Youth Self Report (YSR:
30 items) [20,21] respectively. For each item, the child’s
behaviour has to be rated on a three-point scale, ranging
from 0 (never) to 2 (often).Additionally, adolescents will fill in two subscales of the
Self-Report Delinquency scale (SRD) were used to assess
self-report delinquency [22]. Adolescents will be asked to
indicate on a list of potential delinquent behaviours whether
they engaged in the described behaviours during the past
6 months (‘yes’ or ‘no’). The SRD ‘Violent offending’ (5 items)
and ‘Property offences’ (10 items) scales will be used.
Other types of problems of the adolescent firstly com-
prise anxiety/depression, withdrawal and somatic com-
plaints. These items will be measured with 25 items of
the Youth Self Report [20,21].
In addition substance use (use of alcohol, soft and
hard drugs) will be measured with several questions
from a Dutch questionnaire used in the study Youth and
risky behaviour [23].
Costs items
In addition to change in primary outcomes, the costs of
Multisystemic Therapy compared to CAU will be assessed.
Cost assessment will be done from a societal perspective,
over a time horizon of one year.
Cost components of adolescent antisocial behaviour will
be measured by a modified version of the Trimbos/iMTA
questionnaire for Costs associated with Psychiatric Illness
(TiC-P) [24]. This questionnaire is originally designed to
measure direct and indirect costs of mental health problems.
For the current study, we adjusted the questionnaire to a
version more suitable for assessments of costs related to
child antisocial behaviour [25]. We did this mainly by adding
items about youth and social care. Direct costs of the inter-
ventions as well as indirect costs will be assessed via various
informants, namely professionals, parents and adolescents.
Direct costs concern use of all resources that is directly
related to the intervention and will be estimated through
the review of (time) investment of the professionals, in-
cluding training, overhead, communication with relevant
others, and time and travel costs of professionals involved.
In addition, direct costs of health and youth care utilization
will be assessed via parents (among other things: visits of
the adolescent and parent to health and youth care profes-
sionals, hospitalizations and residential treatments, contact
with judicial authorities and medication use).
Indirect costs are characterized as productivity losses,
due to time lost from work because of the antisocial be-
haviour of the adolescent [26]. Data on productivity loss
will be collected via the Short Form Health and Labour
Questionnaire (SF-HLQ) that is part of the TiC-P [24].
The Short-Form HLQ (SF-HLQ) contains questions
about absence from work, reduced efficiency at work
and difficulties with job performance.
Unit prices and cost calculations
Estimates of unit costs will be based on the Dutch guide-
line prices [25]. Costs of medication use will be based on
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macists allowance. Costs due to productivity losses will
be based on the overall mean hour productivity cost for
men and women, calculated according to the human
capital approach [27]. Multiplying the respective vo-
lumes of resource use with their corresponding unit
prices will result in the associated total costs. Costs will
be calculated in the European currency (Euro). The price
level used will be of 2011.
Quality of life will be assessed with the EuroQol (EQ-
5D) and the Short Form-20 (SF-20), which are validated
tools for measuring general health-related quality of life
[28,29]. The EQ-5D is a self-administered, generic, health-
related quality-of-life questionnaire that contains two sec-
tions, a descriptive section and a valuation section. The
descriptive section consists of five dimensions: mobility,
self-care, usual activities, pain/discomfort and anxiety/de-
pression. Each dimension has three levels of severity: no
problems, some/moderate problems, and extreme prob-
lems. For each severity level a valuation is available that is
based on the judgment of the general public about the
value of this health state. Values on the five dimensions
will be transformed into one single score by applying a for-
mula, ranging from 0 to 1 (with lower scores representing
more problems), and by using the British tariff [30]. We
will use the British tariff because this is used by default in
Europe, and thus the results are more generalizable and
the comparison between studies is more adequate.
The valuation section of the EQ-5D contains a visual
analogue scale, on which the participant rates his/her
health on a vertical, visual analogue scale where the end-
points are labelled ‘Best imaginable health state (score of
100)’ and ‘Worst imaginable health state (score of 0)’.
Valuations of the VAS (original values 0–100) will be
linearly transformed into a 0 to 1 score. This valuation of
health status is a so-called ‘utility’, a relative valuation of a
health condition compared with perfect health and dead.
This method has been found to be efficient and easy to
use, and appears to provide meaningful values for relative
preferences of health and treatment [31]. Thus far the
EQ5D has not been validated in the domain of behavioural
problems, i.e. there are no formal utilities available for se-
vere antisocial behaviour. In a separate study we have gen-
erated valuations for serious behaviour problems in
children and adolescents (Vermeulen et al., submitted).
The SF-20 assesses six important health concepts:
physical functioning, role functioning, social functioning,
mental health, current health perceptions, and pain.
Each dimension has five levels. For each subscale, a scale
score will be calculated. The scale scores can be seen as
multidimensional, health-related quality of life indicator.
The internal consistency of the subscales of the Dutch
SF-20 has proved sufficiently high: Cronbach's alpha for
each subscale was at least .80 [32,33].Data collection procedure
Data will be collected using a standardized self-report
questionnaire in a face-to-face situation. The question-
naires will be administered before the intervention (T1),
directly after the intervention (T2) and six months after
the intervention (T3). Adolescents and their parents will
both receive €10 for filling out the questionnaire. The
therapist will fill out a questionnaire after the treatment
has finished (T2). The questionnaires are also available
in old Berber for the Berber Moroccan families. In
addition, we make use of one Arab translator who will
visit all Arab families.
Sample size
Sample size will be based on testing differences in out-
comes between MST and CAU, at .80 power, an alpha of
.05 and a medium effect size [34]. This leads to 64 par-
ticipants per group. It should be noted that the power to
detect a difference in costs and/or other outcomes is ex-
tremely difficult to assess a priori. Since this is a first at-
tempt to perform a cost-effectiveness study in this area
and no pilot data are available (allowing an assessment
of variability) we cannot present a formal power calcula-
tion. However, to determine a clinically relevant effect
size of 0.5 with a power of 80% at an alpha of 0.05, we
will need 81 in each treatment arm, making 2 × 100 a
probably safe sample size [35].
Statistical analysis
First, descriptive statistics will be performed to describe
the demographic characteristics of the study population.
Second, primary measures of effect will be analysed
using within group comparisons (pre-post treatment)
and between group comparisons. The latter one will use
difference scores (pre-post intervention) after which the
treatment effects of the two treatment conditions will be
compared. Statistical testing will be done using either
the paired t-test or the Wilcoxon signed-rank test for
comparisons within the treatment groups and the un-
paired t-test or the Mann–Whitney U test for compari-
sons between the treatment groups.
Third we will describe the mean costs per respondent in
both treatment groups. Differences in costs between the
intervention group and the control group will presented
based on the trial data, and 95% confidence intervals will
computed based on bootstrap re-sampling with 5000 rep-
lications of the trial data. Separate estimates will be made
for different cost categories. For the cost-effectiveness
analysis, mean annual societal costs will be linked to the
primary measure of effect (Aggressive behaviour and
Delinquent behaviour). A cost utility analysis will link the
EQ-5d based utilities to the cost.
Fourth, point estimates for the incremental cost-
effectiveness and cost utility ratio (ICER) will be computed
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societal costs by the incremental effects at 12 months. Un-
certainty around the ICERs will be estimated using boot-
strapping, generating 5000 replications of the original
dataset. A cost-effectiveness acceptability curve (CEAC)
will be generated to represent the probability that MST is
cost-effective compared to usual care over a range of
thresholds [26,36].Discussion
This paper presents the design of a randomized controlled
trial to investigate the cost-effectiveness of MST in the
Netherlands, an intervention program for families and
youth with severe psychosocial and behavioural problems.
Studying the cost-effectiveness of this intervention is
important in order to provide information to policy
makers on whether the provision of this intervention
represents good value for money. Introducing a cost-
effective evidence based program will result in substan-
tial health gains at acceptable costs. MST can be easily
embedded in both usual mental health care and welfare
services in The Netherlands.Strengths and limitations
This study will contribute to the extension of scientific
knowledge about economic evaluation in the field of child
and youth care. This concerns the evaluation of the actual
balance between costs and effects in a field of care where
this has hardly ever been explored before, i.e. with very
limited sources to derive costs of other outcome valua-
tions from. The study will be conducted as part of a ran-
domized controlled trial. By using such a design, it can be
assumed that any confounding variables are cancelled out.
Furthermore, the study will be conducted as a mul-
ticentre trial. This will increase the generalizability of the
study because this will lead to a large number of partici-
pants, different geographic locations and the ability to
compare results among organizations. We will obtain both
direct and indirect costs across the entire field of youth
care. We will also include quality of life measures. To in-
crease inclusion and prevent loss to follow up, all adoles-
cents and parents will receive assistance in administering
the questionnaires. Finally, most outcome variables will be
assessed via two informants. Multi-informant assessment
is recommended as a way to obtain a more complete pic-
ture of the adolescent than reliance on self- or parent-
report alone [16].
Despite the strengths and innovative aspects of this cost-
effectiveness study, there are some issues that our study is
unable to take into account. First, follow-up is limited to a
period of six months. To determine long-term effects of
the intervention, there should be follow-up after a couple
of years to assess the effects and costs when the adolescentis older. Second, it is to be expected that we will be dealing
with a ‘difficult-to-reach”-population.
Conclusions
Cost-effectiveness is a research topic that has hardly been
looked at in the child and youth care field, both inter-
nationally and nationally [37-40]. More knowledge about
cost-effectiveness in child and youth care will aid policy
makers, health care authorities as well as judicial author-
ities, to set priorities and decide on implementation of
treatment modalities for youth with serious behavioural
disturbances. This study can provide information on both
the feasibility of CEA in this field in general, and on the
cost-effectiveness of MST specifically.
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